Analyst coverage & consensus
The sell-side analysts covering dsm-firmenich and latest Vara consensus figures.
Key performance indicators
Driving us towards our ambitious mid-term targets of:
Full Year 2025 Trading update
February 12, 2026
Driving us towards our ambitious mid-term targets of:
Organic Sales Growth
Adjusted EBITDA margin
Cash to sales conversion ratio
Whether you’re a shareholder, potential shareholder, or analyst, our Investor relations team is on hand to answer your questions.
The sell-side analysts covering dsm-firmenich and latest Vara consensus figures.
A handy overview of the key dates in our financial calendar.
Be the first to know about key news as we continue shaping the future and bringing progress to life.